A November to remember amid US poll results, vaccine hope

Original article by David Rogers
The Australian – Page: 13 & 20 : 12-Nov-20

Australia’s benchmark S&P/ASX 200 has gained 8.8 per cent so far in November, and it is now just 11.5 per cent shy of the record peak of 7,197.2 points in February. The market has been boosted by factors such as the outcome of the US presidential election and the encouraging initial clinical trial results for Pfizer’s coronavirus vaccine candidate. JP Morgan anticipates further upside for equities, forecasting that the global bull run is not yet over.

CORPORATES
STANDARD AND POOR’S ASX 200 INDEX, JP MORGAN AND COMPANY INCORPORATED

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s